sequenc
case
discrep
third
test
use
tiebreak
exampl
approach
hiv
case
detect
specif
diagnost
low
fals
posit
rate
ideal
scenario
sensit
specif
achiev
diagnost
use
poc
approach
laboratorybas
assay
wherev
possibl
howev
lower
specif
toler
harm
overtreat
much
less
critic
miss
diagnosi
infect
screen
syphili
pregnanc
exampl
approach
miss
matern
syphili
lead
stillbirth
preterm
birth
congenit
syphili
third
pregnant
women
compar
harm
overtreat
singl
dose
penicillin
user
friendli
test
easi
perform
step
requir
minim
user
train
prior
knowledg
diagnost
test
typic
result
avail
minut
sampl
collect
enabl
patient
manag
treatment
visit
benefit
rapid
test
versu
accur
test
requir
patient
return
result
previous
demonstr
robust
refer
abil
test
withstand
suppli
chain
temperatur
humid
time
delay
mechan
stress
without
requir
addit
often
costli
transport
storag
condit
exampl
refriger
ideal
test
requir
special
equip
oper
small
portabl
devic
use
solar
batteri
power
deliver
endus
deliveri
refer
organiz
structur
relationship
establish
purpos
coordin
steer
logist
select
procur
ship
store
distribut
deliv
new
health
technolog
ensur
reach
endus
resourceconstrain
set
compar
assur
propos
access
laboratori
resourcelimit
set
improv
dramat
number
qualiti
especi
area
hiv
malaria
test
count
tb
howev
remain
critic
need
wider
rang
diagnost
perform
poc
perspect
undertak
review
assur
benchmark
last
year
assess
factor
contribut
success
failur
assur
diagnost
past
decad
identifi
area
remain
difficult
address
well
lesson
learn
implement
resourcelimit
set
highlight
addit
condit
consid
address
poc
need
sinc
sever
diagnost
test
satisfi
nearli
satisfi
assur
criteria
develop
identifi
major
human
pathogen
includ
test
hiv
malaria
syphili
tb
tabl
hiv
rapid
test
first
test
fulfil
assur
criteria
follow
close
malaria
syphili
rapid
test
recent
nearpoc
test
tb
much
develop
result
advocaci
donor
bill
melinda
gate
hiv
rdt
earli
detect
hiv
infect
critic
compon
hiv
control
programm
worldwid
sinc
earli
day
epidem
sinc
infect
individu
show
specif
symptom
period
viraemia
short
screen
hiv
antibodi
blood
marker
exposur
costeffect
mean
identifi
infect
individu
develop
process
criteria
valid
perform
hiv
antibodi
detect
assay
decad
ago
show
hiv
rdt
use
fingerprick
wholeblood
specimen
accept
perform
compar
laboratorybas
immunoassay
mani
donor
exampl
global
fund
implement
partner
includ
unaid
pepfar
help
affect
countri
procur
introduct
rapid
hiv
test
enabl
earli
detect
prevent
onward
transmiss
result
fund
donor
increas
access
rdt
architectur
provid
nation
hiv
aid
control
programm
hiv
test
success
reach
mani
million
children
adult
lowand
middleincom
countri
ref
two
major
challeng
remain
train
qualiti
assur
thousand
poc
test
site
across
countri
even
wellorgan
control
programm
would
find
difficult
provid
adequ
train
ongo
basi
problem
acut
health
facil
high
turnov
staff
us
centr
diseas
control
prevent
cdc
develop
conveni
mean
extern
qualiti
assur
work
countri
gener
thermal
stabl
profici
panel
ship
everi
poc
test
site
ensur
compet
test
personnel
howev
studi
south
africa
found
hiv
rdt
perform
correctli
although
everi
error
result
incorrect
diagnosi
alarm
realiti
million
test
perform
annual
worldwid
assum
accuraci
rate
mani
million
incorrect
result
per
year
could
potenti
gener
ongo
qualiti
assur
effort
includ
develop
key
polici
qualiti
document
implement
hivrel
poc
test
exampl
poc
technolog
hiv
viral
load
earli
infant
diagnosi
develop
tremend
emphasi
qualiti
given
complex
test
lesson
learn
hiv
rdt
malaria
estim
caus
least
million
death
year
worldwid
subsaharan
africa
microscop
identif
parasit
blood
smear
tradit
mean
diagnos
malaria
patient
present
fever
microscopi
requir
equip
sourc
electr
train
laboratori
technician
malaria
rdt
develop
mani
rural
commun
lack
resourc
date
brand
malaria
rdt
made
approxim
compani
vari
wide
perform
manufactur
qualiti
price
set
prequalif
programm
cdc
foundat
innov
new
diagnost
evalu
test
inform
test
select
procur
nation
malaria
control
programm
countri
permit
sale
malaria
rdt
medicin
counter
qualiti
commod
guarante
price
rdt
brand
us
us
per
test
diagnost
import
caution
price
pressur
ultim
affect
qualiti
hiv
support
donor
select
highqual
rdt
architectur
provid
nation
malaria
control
programm
malaria
rdt
reach
million
patient
everi
year
promis
trend
coupl
effect
bednet
prevent
transmiss
led
call
malaria
elimin
mani
part
world
howev
challeng
remain
futur
malaria
poc
test
global
elimin
malaria
first
highli
accur
test
requir
malaria
speci
affect
human
panspecif
test
usual
expens
rdt
detect
plasmodium
falciparum
p
falciparum
rdt
detect
malari
antigen
histidinerich
protein
hrp
discoveri
parasit
delet
gene
rais
concern
fals
neg
result
ongo
transmiss
also
problem
provid
adequ
train
qualiti
assur
malaria
test
test
remot
poc
site
similar
describ
hiv
rdt
near
futur
countri
progress
toward
malaria
elimin
fund
rdt
may
becom
issu
intens
transmiss
decreas
due
lower
parasit
densiti
infect
individu
sensit
test
need
achiev
costlier
amplif
step
ultrasensit
platform
antigen
detect
also
decreas
number
case
mean
malaria
test
longer
costeffect
thu
difficult
justifi
fund
light
multipl
compet
prioriti
limit
health
budget
syphili
syphili
caus
spirochet
treponema
pallidum
long
latent
period
patient
symptom
remain
infecti
syphili
pregnanc
lead
advers
outcom
stillbirth
miscarriag
babi
born
congenit
syphili
develop
world
chanc
surviv
first
year
life
despit
avail
simpl
diagnost
test
antenat
screen
effect
treatment
singl
dose
longact
penicillin
syphili
reemerg
global
public
health
problem
estim
babi
die
year
result
syphilisassoci
stillbirth
congenit
syphili
larg
lack
access
antenat
screen
rdt
exist
detect
syphili
report
accept
perform
oper
characterist
introduct
rdt
also
accept
patient
health
care
provid
shown
contribut
improv
antenat
care
lowresourc
set
despit
syphili
rdt
success
hiv
malaria
rdt
main
reason
lack
advocaci
polit
translat
evid
nation
polici
lack
fund
make
test
afford
need
lack
nation
control
programm
provid
architectur
need
coordin
differ
aspect
test
ensur
adequ
train
health
care
worker
suppli
commod
cite
key
implement
barrier
africa
dual
hiv
syphili
rdt
test
countri
priorit
elimin
mothertochild
transmiss
mtct
hiv
syphili
recent
review
show
prevent
mother
child
transmiss
pmtct
programm
hiv
result
dramat
decreas
number
hivposit
infant
subsaharan
africa
rate
syphili
screen
pregnant
women
countri
remain
unaccept
low
level
approxim
ref
due
larg
dispar
fund
lack
polit
despit
global
fund
allow
countri
purchas
syphili
rdt
hiv
rdt
sinc
ref
countri
need
har
architectur
provid
hiv
pmtct
programm
screen
women
infect
use
singl
drop
blood
singl
visit
health
care
facil
dual
rapid
hivsyphili
rdt
accept
perform
avail
well
mani
countri
adopt
hiv
andor
syphili
rdt
nation
guidelin
tuberculosi
tb
caus
million
death
year
occur
lowand
middleincom
countri
end
tb
epidem
among
health
target
sustain
develop
goal
tb
lipoarabinomannan
lam
antigen
test
provid
poc
screen
activ
tb
hiv
posit
patient
novel
rapid
test
detect
lam
urin
sampl
provid
result
minut
enabl
earlier
treatment
patient
lam
test
assess
tb
drug
suscept
multidrugresist
tb
threat
global
health
secur
estim
new
case
year
show
resist
rifampicin
rif
effect
firstlin
drug
nucleic
acid
test
nat
tb
avail
provid
highli
sensit
specif
mean
diagnosi
recent
develop
sampleinanswerout
autom
test
devic
allow
simultan
detect
mycobacterium
tuberculosi
mtb
rif
resist
h
min
improv
case
detect
could
decreas
transmiss
though
nat
still
requir
patient
make
return
visit
test
result
treatment
test
system
avail
modul
allow
flexibl
throughput
mtbrif
nearpoc
assay
improv
time
diagnosi
treatment
increas
effici
health
system
introduc
appropri
june
twothird
highburden
mtb
countri
half
countri
high
multidrugresist
mtb
adopt
assay
nation
tb
programm
guidelin
wider
adopt
highperform
assay
would
allow
countri
increas
case
detect
rate
potenti
reach
mileston
end
tb
strategi
although
nation
tb
programm
provid
robust
architectur
implement
new
technolog
challeng
associ
nearpoc
nat
assay
remain
barrier
afford
molecular
assay
devicebas
costli
even
subsidi
expertis
technic
demand
later
flow
rdt
sustain
addit
power
pertest
time
expect
address
barrier
would
improv
patient
outcom
true
poc
test
still
need
overcom
remain
challeng
sampl
prepar
demand
human
resourc
cultur
longstand
microbiolog
goldstandard
highli
specif
also
technic
demand
costli
slowest
diagnost
option
requir
patient
return
anoth
clinic
visit
obtain
test
result
treatment
necessari
thu
conform
well
develop
assur
diagnost
success
poc
test
achiev
high
sensit
need
screen
tool
ensur
true
suspect
case
brought
attent
control
programm
appropri
manag
particular
antibodybas
detect
test
hiv
hepat
c
viru
highli
sensit
antibodi
present
larg
quantiti
blood
blood
sampl
collect
finger
prick
put
directli
test
without
prior
process
also
antibodi
detect
rapid
easi
perform
minim
train
requir
tabl
howev
choic
antibodi
target
affect
test
effect
unless
diagnost
target
specif
intend
infect
potenti
fals
posit
result
due
crossreact
case
dengu
zika
immunoassay
therefor
antibodi
detect
assay
interpret
within
appropri
epidemiolog
context
find
physic
examin
major
disadvantag
antibodybas
test
antibodi
usual
marker
exposur
pathogen
use
distinguish
activ
past
infect
case
test
viscer
leishmaniasi
vl
presumpt
diagnosi
activ
vl
made
use
combin
posit
test
week
fever
splenomegali
true
syphili
rdt
detect
longliv
antibodi
treponem
antigen
thu
diagnos
activ
syphili
antibodi
nontreponem
antigen
appear
infect
declin
month
success
treatment
use
floccul
assay
call
rapid
plasma
reagin
assay
yield
result
minut
requir
electr
oper
centrifug
process
serum
whole
blood
shaker
cardiolipin
antigen
combin
treponem
nontreponem
rapid
test
develop
immunochromatograph
test
later
flow
format
accept
perform
characterist
antigen
detect
poc
test
chlamydia
gonorrhoea
suffer
three
major
drawback
tabl
first
specimen
use
sexual
transmit
infect
usual
urethr
cervic
vagin
swab
requir
multipl
step
solubil
bacteria
free
antigen
reaction
captur
antibodi
sometim
requir
heat
step
add
complex
cost
poc
test
urin
prefer
specimen
men
infect
current
poc
test
requir
urin
centrifug
step
concentr
bacteria
process
reaction
anoth
common
drawback
antigen
detect
test
potenti
fals
posit
result
due
crossreact
antigen
close
relat
bacteri
viral
speci
especi
true
polyclon
antibodi
use
captur
antibodi
final
common
disadvantag
current
antigen
detect
poc
assay
low
sensit
often
requir
bacteria
rdt
becom
posit
malaria
rdt
except
drawback
parasit
present
larg
quantiti
blood
preprocess
concentr
step
requir
antigen
detect
poc
test
low
sensit
may
due
low
concentr
target
antigen
ineffici
extract
limit
optim
reagent
hamper
chlamydia
gonorrhoea
test
howev
gift
et
al
show
rapid
chlamydia
test
sensit
lead
infect
patient
treat
compar
nat
requir
patient
return
test
result
call
rapid
test
paradox
also
recent
seen
assay
earli
infant
diagnosi
hiv
sensit
still
lead
higher
diagnost
yield
nat
perform
dri
blood
spot
sent
remot
antenat
clinic
nat
offer
sensit
specif
altern
antigen
detect
assay
nucleic
acid
target
select
genom
sequenc
high
specif
amplif
process
increas
sensit
fairli
rapid
tabl
exampl
nearpoc
tb
diagnost
involv
primerbas
amplif
mtb
dna
specif
includ
region
associ
rif
drug
resist
thu
nat
test
gener
highli
sensit
specif
antigenor
antibodybas
test
may
help
inform
drug
suscept
instrument
avail
highthroughput
screen
patient
subsidi
bring
test
cost
us
equip
capabl
four
test
time
cost
us
may
prohibit
highincid
region
thu
truli
poc
diagnost
base
nat
without
need
equip
still
promis
realiti
yet
criteria
origin
accept
requir
equipmentfre
perhap
one
critic
origin
defin
wide
rang
nearpoc
nat
develop
use
outsid
laboratori
set
assay
autom
requir
minut
handson
time
minim
train
nearpoc
devic
come
seal
unit
intern
selfcalibr
make
easier
ensur
qualiti
test
also
equip
data
transmiss
capabl
make
platform
attract
context
diseas
surveil
epidem
prepared
nearpoc
devic
broad
menu
diagnost
target
make
capit
cost
purchas
devic
less
issu
reagent
premeasur
dri
readi
hydrat
introduct
specimen
howev
nearpoc
nat
cartridg
expens
manufactur
afford
develop
countri
without
subsidi
rapid
advanc
miniatur
materi
scienc
electron
data
transmiss
recent
year
made
minim
instrument
realiti
new
diagnost
includ
use
smart
phone
wide
avail
custom
develop
low
cost
use
dongl
connect
smart
phone
microfluid
disc
detect
hiv
syphili
antibodi
fingerprick
blood
allow
phone
power
reaction
interpret
result
transmit
data
central
databas
smart
phonebas
poc
assay
current
undergo
clinic
trial
use
smart
phone
power
nat
develop
play
import
role
futur
poc
applic
particular
consider
interest
shown
util
mobil
phone
reader
connect
rdt
use
rfid
radio
frequenc
identif
prevent
error
subject
interpret
transcript
phonebas
diagnost
attract
option
regulatori
approv
rapid
updat
phone
softwar
affect
test
perform
import
challeng
defin
quantifi
risk
benefit
success
need
celebr
signific
challeng
remain
first
diagnost
perfect
countri
continu
struggl
defin
accept
risk
fals
posit
neg
result
novel
diagnost
technolog
may
provid
increment
clinic
benefit
develop
world
popul
resid
rural
area
sustain
develop
goal
urg
countri
provid
univers
health
coverag
leav
one
behind
tradeoff
accuraci
sensit
specif
access
user
friendli
rapid
deliver
becom
paramount
imposs
give
absolut
valu
across
differ
test
sensit
specif
remain
critic
select
ideal
test
posit
neg
predict
valu
depend
preval
diseas
well
characterist
diagnost
test
taken
account
studi
perform
determin
quantit
tradeoff
accept
analysi
syphili
screen
compar
use
laboratorybas
immunoassay
treponem
rdt
tanzania
show
test
sensit
use
sophist
laboratori
realist
access
popul
rapid
later
flowbas
antibodi
test
sensit
use
level
health
care
system
effect
give
correct
diagnosi
mani
popul
highlight
test
evalu
pure
technic
perform
rather
diagnost
perform
clinic
impact
train
qualiti
assur
assur
qualiti
test
test
biggest
challeng
test
decentr
poc
mani
rapid
test
variou
manufactur
avail
test
qualiti
may
impact
accur
inconsist
diagnosi
across
differ
site
studi
show
high
rate
error
observ
even
perform
simpl
rdt
hiv
malaria
qualiti
test
requir
profici
panel
sent
poc
test
site
nation
refer
laboratori
includ
posit
neg
control
box
test
allow
test
approv
arriv
destin
first
use
recent
nine
african
countri
develop
nation
system
assur
qualiti
poc
test
hiv
data
connect
test
site
qualiti
assur
result
link
test
result
poc
test
site
central
databas
trigger
alert
correct
action
suppli
chain
softwar
also
link
connect
solut
avoid
stockout
demonstr
valu
novel
diagnost
technolog
valu
diagnost
goe
beyond
technolog
test
need
match
test
environ
includ
popul
characterist
preval
target
diseas
comorbiditiescoinfect
health
system
characterist
nation
programm
take
advantag
rapid
turnaround
time
assur
test
streamlin
patient
pathway
increas
effici
health
care
system
rollout
poc
diagnost
requir
use
implement
scienc
ensur
success
take
account
cultur
behaviour
socioeconom
health
system
context
includ
care
assess
accept
feasibl
link
possibl
increas
stress
health
systemprovid
test
introduc
set
thu
far
limit
test
perform
studi
use
genexpert
mtbrif
tb
test
show
new
diagnost
test
would
expect
impact
outcom
test
introduct
accompani
chang
patient
pathway
practic
studi
highlight
import
programmat
monitor
impact
novel
technolog
beyond
studi
usual
conduct
control
condit
likewis
sameday
test
treatment
use
syphili
rdt
strengthen
health
system
amazon
forest
rural
china
polici
maker
involv
test
introduc
within
appropri
social
cultur
context
exampl
peru
women
normal
need
present
six
time
largest
matern
hospit
lima
prenat
syphili
screen
complet
treatment
provid
introduct
rapid
syphili
test
streamlin
test
treatment
one
visit
reduc
patient
outofpocket
expens
increas
effici
busi
health
care
facil
detail
analys
conduct
accur
determin
econom
impact
mani
avail
test
includ
diagnost
cost
versu
overal
econom
impact
benefit
intuit
import
often
difficult
quantifi
would
therefor
extrem
use
econom
analysi
tool
major
diseas
condit
develop
understand
cost
implic
cost
structur
would
accept
health
servic
implement
exampl
may
necessari
accept
cost
tradeoff
address
global
health
threat
exampl
zika
ebola
speed
intervent
critic
state
lowcost
diagnost
test
remain
critic
resourcelimit
set
past
two
decad
biggest
driver
diagnost
develop
wellresourc
diseas
hiv
malaria
tb
recent
year
increas
frequenc
sever
global
health
emerg
caus
infecti
diseas
epidem
potenti
sever
acut
respiratori
syndrom
sar
coronaviru
middl
east
respiratori
syndrom
coronaviru
mer
cov
ebola
zika
viru
made
global
commun
realiz
need
acceler
assur
test
develop
valid
manufactur
deploy
need
innov
rapid
detect
technolog
assur
allow
multiplex
detect
panel
pathogen
major
caus
respiratori
ill
haemorrhag
fever
enter
infect
singl
specimen
test
identifi
caus
outbreak
also
use
process
multipl
specimen
high
throughput
throughout
outbreak
anoth
major
driver
test
develop
need
cheaper
better
faster
test
use
poc
reduc
inappropri
antimicrobi
use
estim
peopl
die
untreat
condit
due
antimicrobi
resist
amr
everi
year
worldwid
amr
continu
spread
million
peopl
may
die
resist
infect
annual
econom
cost
estim
trillion
primari
care
level
simpl
rapid
test
use
distinguish
bacteri
nonbacteri
caus
fever
respiratori
enter
infect
would
allow
health
care
provid
reduc
antibiot
use
preserv
futur
gener
oneil
report
also
point
test
identifi
pathogen
antibiot
suscept
poc
would
allow
safe
use
firstlin
drug
drug
combin
save
health
care
system
stimul
interest
innov
diagnost
test
use
poc
sever
countri
set
challeng
prize
unit
kingdom
announc
longitud
prize
million
seek
afford
accur
fast
easytous
test
bacteri
infect
allow
health
profession
worldwid
administ
right
antibiot
right
time
challeng
current
ongo
final
submiss
inform
avail
http
longitudeprizeorg
septemb
us
depart
health
human
servic
announc
challeng
prize
competit
million
award
one
novel
innov
poc
diagnost
would
clinic
public
health
valu
combat
develop
spread
antibiot
resist
bacteria
inform
avail
http
dpcpsinihgovamrchalleng
prize
may
catalys
new
technolog
still
guarante
sustain
test
resourcelimit
countri
given
cost
critic
factor
woven
everi
step
need
bring
sustain
test
donor
funder
diagnost
bill
melinda
gate
foundat
global
fund
unitaid
aid
agenc
nation
govern
pepfar
dfid
play
critic
role
incentiv
diagnost
innov
address
market
dynam
technolog
advanc
support
innov
technolog
market
medic
devic
matur
enabl
connect
diagnost
becom
use
tool
epidemiolog
patient
care
track
research
amr
outbreak
surveil
abil
digit
data
laboratori
poc
platform
includ
later
flow
rdt
result
standard
interpret
result
allow
data
link
profici
test
ensur
test
qualiti
reduc
interpret
transcript
error
remot
monitor
poc
instrument
function
util
connect
allow
programm
optim
instrument
placement
algorithm
adopt
suppli
manag
alert
built
system
rais
alarm
unusu
trend
outbreak
applic
mobil
devic
relat
technolog
health
care
improv
patient
access
health
inform
treatment
offer
possibl
diagnos
track
assess
impact
infecti
diseas
intervent
across
world
smart
devic
also
use
automat
add
data
central
databas
allow
system
assess
likelihood
diagnosi
predict
diseas
outbreak
machin
learn
provid
rout
smart
diagnost
incorpor
histor
epidemiolog
data
make
diagnos
accur
final
new
engin
field
internet
thing
iot
industri
print
electron
promis
add
significantli
technolog
chosen
incorpor
new
diagnost
devic
mani
technolog
aim
highvolum
lowcost
distribut
manufactur
thu
fit
well
goal
poc
diagnost
new
detector
light
sourc
also
suggest
incorpor
test
could
allow
accur
result
read
possibl
multiplex
clear
origin
assur
criteria
remain
relev
opportun
exist
improv
futur
diagnost
incorpor
new
technolog
element
provid
realtim
qualiti
control
test
treatment
overcom
difficulti
specimen
collect
andor
process
current
limit
scalingup
diagnost
resourcelimit
area
therefor
propos
two
addit
criteria
r
realtim
connect
e
eas
specimen
collect
environment
friendli
origin
assur
creat
new
acronym
reassur
tabl
use
test
effect
survey
treat
patient
critic
obtain
analys
result
poc
howev
one
main
challeng
poc
test
ensur
result
rapidli
provid
patient
test
complet
formid
challeng
test
decentr
hundr
thousand
differ
site
health
care
worker
consist
skill
read
test
result
lead
risk
incorrect
data
record
andor
transmit
one
solut
would
allow
analysi
test
result
central
level
consist
diagnosi
epidemiolog
surveil
mani
manufactur
embed
connect
poc
nearpoc
instrument
exampl
aler
pima
poc
devic
manufactur
develop
innov
connect
solut
use
mobil
phone
read
result
later
flow
assay
provid
electron
result
exchang
third
option
would
includ
connect
directli
onto
test
ideal
connect
includ
collect
transmiss
test
data
also
analysi
provid
feedback
immedi
patient
treatment
surveil
addit
barcod
twodimension
code
electron
storag
test
number
data
point
collect
includ
manufactur
inform
exampl
lot
number
date
expiri
date
stock
avail
possibl
even
environment
condit
temperatur
humid
test
manufactur
transport
store
use
instrument
test
mainten
machin
data
collect
thu
connect
solut
increas
qualiti
assur
poc
test
would
allow
central
realtim
decisionmak
even
across
tier
laboratori
system
outbreak
investig
global
health
emerg
move
forward
critic
import
make
provis
poor
nonexist
internet
avail
support
sustain
standard
system
develop
compat
link
central
databas
eas
specimen
collect
specimen
collect
process
may
need
indepth
develop
first
ideal
noninvas
specimen
collect
given
test
becom
avail
self
home
test
second
sampl
come
mani
differ
format
blood
urin
sputum
stool
swab
breath
requir
differ
prepar
depend
test
perform
may
includ
concentr
sampl
possibl
titrat
purif
lyse
cell
target
amplif
process
easili
perform
laboratori
remain
solut
collect
perform
task
poc
oral
test
hiv
hepat
c
viru
good
exampl
advanc
noninvas
sampl
although
collect
devic
expens
blood
collect
via
dispos
capillari
tube
relat
given
rapid
later
flow
antigen
detect
test
often
lower
sensit
extra
process
step
heat
form
extract
requir
use
specimen
blood
environment
friendli
advanc
technolog
made
assur
requir
equip
somewhat
less
daunt
howev
light
diagnost
test
perform
urban
rural
area
could
futur
effort
devot
environment
impact
test
cumul
effect
mani
ten
thousand
test
perform
remot
site
away
laboratori
infrastructur
may
pose
health
environment
risk
put
strain
limit
resourc
exampl
includ
plastic
use
current
rapid
test
recycl
give
toxic
fume
burn
test
cartridg
may
even
contain
harm
chemic
need
dispos
properli
recycl
materi
use
possibl
hous
substrat
matrix
materi
reagent
use
test
paper
obviou
choic
substrat
materi
mani
inher
advantag
standard
plastic
materi
see
increas
usag
later
flow
format
paper
base
format
well
micro
paperbas
analyt
devic
pad
recent
cellfre
synthet
gene
network
vitro
applic
poc
achiev
freezedri
cellfre
system
onto
paper
increas
stabil
room
temperatur
easili
transport
store
simpli
reactiv
ad
water
factor
also
need
consid
dispos
test
reagent
clinic
sampl
materi
use
activ
compon
electron
track
electrod
assur
criteria
valuabl
framework
develop
devic
method
detect
major
human
diseas
challeng
poc
context
howev
last
decad
new
technolog
envisag
avail
time
first
assur
criteria
definit
given
rise
possibl
includ
new
consider
next
gener
devic
test
propos
acronym
reassur
design
futur
diagnost
test
address
import
prioriti
global
health
emerg
amr
ideal
test
would
one
combin
best
exist
diagnost
world
instrument
laboratori
base
test
later
flow
test
technolog
current
develop
fig
would
provid
import
extens
diagnost
laboratori
system
fulfil
sustain
develop
goal
one
left
behind
term
effect
health
care
servic
deliveri
test
creat
form
strong
collabor
partnership
across
mani
disciplinari
boundari
look
toward
futur
data
connect
link
costeffect
assur
diagnost
laboratori
system
form
backbon
health
care
system
provid
realtim
data
evidencebas
diseas
control
prevent
strategi
effici
health
system
improv
patient
outcom
